Follow the people · Insider
Jeffrey Gerald Mifek
Jeffrey Gerald Mifek files insider transactions with the SEC as a chief clinical-medical affairs of Femasys (FEMY). We hold 1 disclosed purchase or sale filed since 11 August 2026, 1 of them in the last 90 days.
- Files forFEMY
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure11 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 July 2026 — 7 August 2026Chief Clinical-Medical Affairs · Femasys (FEMY)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
4 entries, newest first — one per disclosure report, one per Form 4 line- was granted 6,250 shares of Femasys (a derivative holding)SEC Form 411 August 2026Stock Option (Right to Buy) · traded 6 July 2026 · filed 11 August 2026
- ▲ bought on the open market 3,125 shares of FemasysSEC Form 411 August 2026Common Stock · traded 7 August 2026 · filed 11 August 2026
- was granted 3,125 shares of Femasys (a derivative holding)SEC Form 411 August 2026Common Stock Purchase Warrant · traded 7 August 2026 · filed 11 August 2026
- was granted 3,125 shares of Femasys (a derivative holding)SEC Form 411 August 2026Common Stock Purchase Warrant (Milestone) · traded 7 August 2026 · filed 11 August 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.